Paul Hopper has over 20 years experience in international public...

Paul Hopper has over 20 years experience in international public company markets primarily in the medical, healthcare and biotechnology sectors, with a focus on start-up and rapid growth companies, and has served as either Chairman, non-executive director or CEO, of fourteen public companies in the US, Australia and Asia, including sub-committee roles for audit, governance, remuneration and nomination. His experience includes four IPOs and two public company mergers and extensive capital markets experience in debt and equity raisings in Australia, Asia, US and Europe. Sector experience includes biotechnology, life sciences, medical & healthcare services, nutraceuticals, and e-commerce.
Looks like we now a Harvard Educated Businessman on board, who has expertise in Company buy outs and takeovers.
Worth getting at least a little excited over. Noticing now quite a few x trades at 045.